| Calvin A Roseth, MD | |
|
901 4th St Nw, Watertown, SD 57201-1558 | |
| (605) 886-8471 | |
| (605) 886-9317 |
| Full Name | Calvin A Roseth |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 901 4th St Nw, Watertown, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215916739 | NPI | - | NPPES |
| 6001962 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2698 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Calvin A Roseth, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Calvin A Roseth, MD 901 4th St Nw, Watertown, SD 57201-1558 Ph: (605) 886-8471 |
News Archive
As Black women continue to have the lowest breastfeeding initiation and duration rates in the United States, researchers examined factors associated with breastfeeding disparities and inequities through the lens of critical race theory and the social-ecological model in a new Perspective in the Journal of Nutrition Education and Behavior, published by Elsevier.
With the peak of summer now upon us, many of us will take time to kick off the shoes and take a walk on the beach or maybe on a grassy field in the local park. Some may even hop into a river or creek to cool off. No worries, right? Well, for some people, relaxing barefoot comes with some concern. Specifically, those with diabetes need to pay close attention to their feet.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
German regulatory authorities have granted approval to Biothera to conduct two open label, multicenter, randomized Phase II clinical trials studying Imprime PGG® administered in combination with monoclonal antibodies and chemotherapy in patients with non-small cell lung cancer (NSCLC), the company announced today.
› Verified 7 days ago
Salem N Maaliki, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7953 Fax: 605-882-7954 | |
Kathryn Ann Aune, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 1st Ave Sw Ste A, Watertown, SD 57201 Phone: 612-562-9390 Fax: 605-309-7827 | |
Dr. Deepali Shah, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 506 1st Ave Se, Watertown, SD 57201 Phone: 605-886-8482 Fax: 605-884-4332 | |
Dr. Ravishankar V Kalaga, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7000 Fax: 605-882-7607 | |
Dr. Svien A Senne, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7000 Fax: 605-882-7819 | |
Dr. Bipinkumar Amin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-6800 Fax: 605-882-6831 |